top of page
Companies in the News
Novartis inks $1B-plus biobucks deal with Flagship's Generate
Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop protein...
Sep 25, 2024
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and 52% of those who...
Jun 3, 2024
Incyte Completes Acquisition of Escient Pharmaceuticals
Acquisition strengthens Incyte’s Inflammation and Autoimmunity (IAI) pipeline and reinforces commitment to bring innovative solutions to...
May 30, 2024
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Pharmaceuticals for $750 million. The...
Apr 23, 2024
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
Acquisition transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end...
Mar 25, 2024
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Initial studies will focus on infants and young children; company plans to begin clinical trials in the United States and Australia in...
Feb 6, 2024
eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion
Median progression free survival (mPFS) of 7.4 months in the ZFA expansion cohort evaluating zotatifin in combination with fulvestrant...
Dec 8, 2023
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study
10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike...
Sep 28, 2023
Generate:Biomedicines Announces Close of $273M Series C Financing
Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually Company has raised nearly $700 million in...
Sep 14, 2023
bottom of page